|
|
||||||||
1 Thoracic Surgery Research Laboratory, Toronto General Hospital, Toronto M5G 2C4; 3 Division of Respiratory Medicine, Mount Sinai Hospital, Toronto M5G 1X5; 5 Medical Research Council Group in Lung Development and Lung Biology Program, Hospital for Sick Children, and Departments of 2 Surgery, 4 Medicine, 6 Pediatrics, and 7 Physiology, University of Toronto, Toronto, Ontario, Canada M5G 1A8
Decreased nitric oxide (NO) production has been reported during lung transplantation in patients. To study the effects of ischemia and reperfusion on endogenous NO synthase (NOS) expression, both an ex vivo and an in vivo lung injury model for transplantation were used. Donor rat lungs were flushed with cold low-potassium dextran solution and subjected to either cold (4°C for 12 h) or warm (21°C for 4 h) ischemic preservation followed by reperfusion with an ex vivo model. A significant increase in inducible NOS and a decrease in endothelial NOS mRNA was found after reperfusion. These results were confirmed in a rat single-lung transplant model after warm preservation. Interestingly, protein contents of both inducible NOS and endothelial NOS increased in the transplanted lung after 2 h of reperfusion. However, the total activity of NOS in the transplanted lungs remained at very low levels. We conclude that ischemic lung preservation and reperfusion result in altered NOS gene and protein expression with inhibited NOS activity, which may contribute to the injury of lung transplants.
ischemia-reperfusion; acute lung injury; early graft dysfunction
This article has been cited by other articles:
![]() |
G. Yung Lung Transplantation and Pulmonary Hypertension Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 149 - 156. [Abstract] [PDF] |
||||
![]() |
L. Zhang, S. Kumar, A. Kaminski, C. Kasch, C. Sponholz, C. Stamm, Y. Ladilov, and G. Steinhoff Importance of endothelial nitric oxide synthase for the hypothermic protection of lungs against ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 969 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF] |
||||
![]() |
S. Teng, S. Kurata, I. Katoh, G. S. Georgieva, T. Nosaka, C. Mitaka, and T. Imai Cytokine mRNA expression in unilateral ischemic-reperfused rat lung with salt solution supplemented with low-endotoxin or standard bovine serum albumin Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L137 - L142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Meade, J. T. Granton, A. Matte-Martyn, K. McRae, B. Weaver, P. Cripps, and S. H. Keshavjee A Randomized Trial of Inhaled Nitric Oxide to Prevent Ischemia-Reperfusion Injury after Lung Transplantation Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1483 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Karamsetty and J. R. Klinger NO: More Than Just a Vasodilator in Lung Transplantation Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 1 - 5. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |